Experiment I
Fifty-two litters of BALB/c mice were randomly divided into ten groups of between 50 and 60 animals. The mice were injected subcutaneously, either once during the first 24 hours after birth, or once daily on the first five days of life. Group 1 received one injection of 100,ug. 2-naphthylamine; Group 2, five injections each of 100,tg. 2-naphthylamine; Group 3, one injection of 100 ,ug. 2-naphthylhydroxylamine; Group 4, five injections each of 100 ,ug. 2-naphthylhydroxylamine; Group 5, one injection of 100 ,ug. 2-acetylaminofluorene; Group 6, five injections each of 100,tg. 2-acetylaminofluorene; Group 7, one injection of 200,g. ethyl methane sulphonate; Group 8, five injections each of 200,g. ethyl methane sulphonate. All doses were given in 0X02 ml. arachis oil. Group 9 received one injection of 0X02 ml. arachis oil and Group 10, five injections of arachis oil.
Surviving mice were killed after 40 weeks. The incidence of lung adenomas in the survivors is shown in Table I . No other tumours were observed. Neither one nor five injections of 2-naphthylamine or of ethyl methane sulphonate yielded a significantly greater incidence of lung tumours than that in the respective control groups. The lung tumour incidence was significantly higher than the control level when the mice received five injections of 2-naphthylhydroxylamine (P < 0.05) and 2-acetylaminofluorene (P < 0'02). The mean number of tumours per survivor was also significantly greater in these two groups (P < 0-01) and in the group which had only one injection of 2-naphthylhydroxylamine (P < 0.01).
Experiment 2
Thirty-two litters of BALB/c mice were randomly divided into four groups. All of the mice were injected subcutaneously once daily on each of the first five days of life. Group 1 received five injections of 100 jIg. 2-naphthylamine; Group 2, five injections of 100 ,ig. 2-naphthylhydroxylamine; and Group 3, five injections of 200,Ig. ethyl methane sulphonate. The compounds were suspended in 0*02 ml. 3% aqueous gelatine. Group 4 received five injections of aqueous gelatine.
The survivors were killed at 50 weeks of age. Table IJ shows the incidence of pulmonary adenomas. No other tumours were seen. 2-naphthylhydroxylamine and ethyl methane sulphonate induced a significantly higher incidence (P < 0 001) and multiplicity (P < 0.01 and P < 0-05, respectively) of lung tumours than that in the control group. Both incidence and multiplicity of lung adenomas were greater in 2-naphthylamine-treated mice than in the controls, but the difference was not significant.
Experiment 3
Two groups of between 50 and 60 C57B1 mice were composed om 19 randomly distributed litters. The mice were injected once daily for the first five days of life. Group 1 received five injections of 200 jug. ethyl methane sulphonate in 0*02 ml. arachis oil, and Group 2 were given five injections of arachis oil only. The survivors were killed between the 55th and 60th weeks of the experiment. No tumours developed in control animals. The lung tumour incidence in the ethyl methane sulphonate-treated mice is shown in Table II. One mouse, which died at 23 weeks, had a malignant lymphoma. .c (Pietra et at., 1961; Roe et al., 1961) . This suggests that the carcinogens spread throughout the body. The same dose of ethyl methane sulphonate in arachis oil did however induce lung tumours in significantly more C57B1 mice than in the controls, in which there were none. The incidence of pulmonary adenomas was low in the treated group but C57B1 is known to be a strain resistant to the induction of lung tumours (Shimkin, 1940) .
Repeated injections of 2-naphthylhydroxylamine, given in arachis oil or aqueous gelatine, induced a greater incidence and multiplicity of lung tumours in surviving mice than in the controls. A single injection of the compound at birth increased the mean number of tumours per mouse above the control level. That the activity of 2-naphthylhydroxylamine was markedly greater than that of the parent amine, 2-naphthylamine, is in agreement with the theory that the aromatic amines such as 2-naphthylamine are converted to active proximate carcinogens by metabolic processes. Clayson (1953) suggested that the aromatic amines were carcinogenic because of their conversion to ortho-hydroxylamines. Some of these compounds were shown to be carcinogenic by the technique of bladder pellet implantation in mice (Bonser, Bradshaw, Clayson and Jull, 1956 ), but 2-naphthylhydroxylamine, a metabolite formed by N-hydroxylation (Boyland, Manson and Nery, 1960) , has induced a higher incidence of bladder tumours than any other compound tested (Bonser et al., 1963) . More than half of 66 mice implanted with pellets of 2-naphthylhydroxylamine mixed with stearic acid developed bladder tumours. None were found in a group of 74 mice implanted with 2-naphthylamine/stearic acid pellets. Intraperitoneal injections of 2-naphthylhydroxylamine induced abdominal tumours in nine out of fifteen rats, while only two of fourteen rats developed sarcomas following similar treatment with 2-naphthylamine (Boyland, Dukes and Grover, 1963) .
It is possible that the failure of 2-naphthylamine to induce tumours when injected into mice during the first week of life is due to the immaturity of the microsomal enzymes which carry out N-hydroxylation. Jondorf, Maickel and Brodie (1958) found that newborn mice and guinea-pigs are deficient in certain drug-metabolising enzymes in liver microsomes. Enzyme systems for metabolising amidopyrine, phenacetin and hexobarbitone were absent 24 hours after birth. The mechanisms appeared during the first week and increased in activity until the animals were about eight weeks old.
2-Acetylaminofluorene, another aromatic amine, yielded significantly more lung tumours than seen in control mice, when five doses were given to newborn mice. It is also a more potent carcinogen for the adult mouse than 2-naphthylamine (Hartwell, 1951; Shubik and Hartwell, 1957) , inducing tumours of the liver, kidney, bladder, thyroid and breast.
